Consultants
Total Trials
3
As Lead Sponsor
0
As Collaborator
Total Enrollment
1,148
NCT02547818
Safety and Efficacy Study of ALZT-OP1 in Subjects With Evidence of Early Alzheimer's Disease
Phase: Phase 3
Role: Collaborator
Start: Sep 15, 2015
Completion: Nov 18, 2020
NCT04170309
Collection of Data of Ceftobiprole Treated Patients: Comparison of Patients With and Without Certain Diseases
Phase: N/A
Start: Mar 30, 2020
Completion: Jun 9, 2023
NCT03088111
An Open Label Field Study of Anthim (Obiltoxaximab) in Subjects Exposed to B. Anthracis
Phase: Phase 4
Start: Dec 31, 2023
Completion: Dec 31, 2025
Loading map...